THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION

QR Code

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION

Data on the mechanisms of cardiomyocyte apoptosis in myocardial infarction are presented. It has been experimentally established that the ratio of the number of cardiomyocytes with signs of apoptosis and necrosis is 30:1 already 2 hours after acute artery occlusion. This fact points out the leading...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. N. Zakirova, B. N. Garifullin, N. E. Zakirova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2017-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	myocardial infarction apoptosis beta-blocker carvedilol
Online Access:	https://www.rpcardio.online/jour/article/view/1581
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2016-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

EVALUATION OF CARVEDILOL EFFECTS ON THE BASIC DATA OF LEFT VENTRICLE SYSTOLIC AND DIASTOLIC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION
by: L. N. Mingazetdinova, et al.
Published: (2001-08-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

SERUM MARKERS OF APOPTOSIS AND CONVENTIONAL RISK FACTORS IN PATIENTS WITH MYOCARDIAL INFARCTION AND HEALTHY RESIDENTS OF ARKHANGELSK REGION: TRENDS, CAUSES, AND CONSEQUENCES
by: A. S. Yakovleva, et al.
Published: (2013-06-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

EFFICACY AND SAFETY OF BETA-ADRENOBLOCKER TREATMENT DURING POSTOPERATIONAL PERIOD AFTER EXTRACARDIAL SURGERY - A PARADIGM SHIFT?
by: Yu. V. Shchukin, et al.
Published: (2014-09-01)

Polymorphic variants of the genes for enzymes of the antioxidant system, apoptosis and inflammation as potential predictors of myocardial infarction
by: T. R. Nasibullin, et al.
Published: (2024-11-01)

Carvedilol: New pharmacological approaches
by: Mohamed Alaa Hafez, et al.
Published: (2024-12-01)

LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION
by: N. E. Zakirova, et al.
Published: (2016-05-01)

PERI-OPERATIVE INJURY AND MYOCARDIAL INFARCTION
by: V. V. Lomivorotov, et al.
Published: (2019-05-01)

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Endothelial dysfunction and hemostasis in acute myocardial infarction before and after Trombovazim therapy
by: Ye. F. Kotovshchikova, et al.
Published: (2011-02-01)

LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN PATIENTS WITH ANTERIOR WALL MYOCARDIAL INFARCTION AND DRUG PREVENTION OF CONGESTIVE HEART FAILURE (A LONG-TERM OBSERVATION)
by: M. T. Beyshenkulov, et al.
Published: (2003-08-01)

Type 2 Myocardial Infarction on the Background of Coronary Vasospasm and Invasive Tactics of Its Diagnosis and Treatment
by: D. Yu. Gamayunov, et al.
Published: (2023-10-01)

ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES
by: E. I. Bambysheva, et al.
Published: (2016-01-01)

COMPARATIVE EFFECTIVENESS OF DIFFERENT DRUG COMBINATIONS IN REGARD TO END-POINT INCIDENCE DURING POST-INFARCTION PERIOD
by: R. M. Gafurova, et al.
Published: (2011-08-01)

Cardiac volume load and heart failure prognosis in patients with uncomplicated myocardial infarction
by: M. T. Beyshenkulov, et al.
Published: (2008-04-01)

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION
by: M. E. Statsenko, et al.
Published: (2016-01-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

MODERN POTENTIAL OF MYOCARDIAL INFARCTION TREATMENT IN THE POLYCLINIC SETTINGS (LECTURE)
by: Yu. I. Nesterov
Published: (2013-06-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

Clinical and diagnostic significance of apoptosis markers in myocardial infarction in the setting of chronic obstructive pulmonary disease
by: A. V. Naumov, et al.
Published: (2021-12-01)

PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)
by: S. B. Fitilev, et al.
Published: (2017-05-01)

Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment
by: Yu. A. Bunin, et al.
Published: (2018-09-01)

Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin
by: O. A. Osipova, et al.
Published: (2021-11-01)

The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years?
by: S. Yu. Martsevich
Published: (2024-10-01)

SPONTANEOUS DISSECTION OF CORONARY ARTERY AS A CAUSE OF ACUTE MYOCARDIAL INFARCTION
by: E. A. Protasova, et al.
Published: (2014-10-01)

ATYPICAL CLINICAL COURSE OF THE ACUTE MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTIC OF PATIENTS, MANAGEMENT AND OUTCOMES (DATA FROM REGISTRY OF ACUTE MYOCARDIAL INFARCTION)
by: A. А. Garganeeva, et al.
Published: (2016-08-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Therapeutic hypothermia in acute myocardial infarction
by: V. V Ryabov, et al.
Published: (2023-08-01)